Cancer cells, specifically tumors, monopolize part of the body’s
blood supply for their own use. Anti-angiogenic therapy uses specially
engineered drugs in an attempt to destroy cancerous cells by damaging
that blood supply.
Angiogenesis is the process in which the body forms new blood vessels.
Anti-angiogenic drugs are designed to target specific cancer cells and
stop them from forming new blood vessels so that the cancer cells cannot
survive. Anti-angiogenic therapy is usually not employed on its own, but
as part of a broader chemotherapy treatment.
At the Institute, our oncologists will consult with you about whether anti-angiogenic
therapy can be an effective part of your treatment. If so, we can administer
the therapy here in our offices.